Open AccessNectin-1 Is a Marker of Thyroid Cancer Sensitivity to Herpes Oncolytic Therapy
Author(s) -
YuYao Huang,
Zhenkun Yu,
ShuFu Lin,
Sen Li,
Yuman Fong,
Richard J. Wong
Publication year - 2007
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2007-0040
Subject(s) - medicine , thyroid cancer , context (archaeology) , anaplastic thyroid cancer , oncolytic virus , oncology , refractory (planetary science) , cancer , thyroid , biology , paleontology , astrobiology
The prognosis for patients diagnosed with anaplastic thyroid cancer is dismal, with a median survival time of only 6 months. Novel therapies are needed for these and other thyroid cancers that are refractory to conventional therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom